JAK2 amplification

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

JAK2 amplification	Non Small Cell Lung Cancer	JAK2 amplification	Non Small Cell Lung Cancer	nivolumab Resistant: C3 – Early Trials nivolumab Resistant : C3	nivolumab Resistant: C3 – Early Trials nivolumab Resistant : C3
JAK2 amplification	Acute Myelogenous Leukemia	JAK2 amplification	Acute Myelogenous Leukemia	ruxolitinib Sensitive: D – Preclinical ruxolitinib Sensitive : D	ruxolitinib Sensitive: D – Preclinical ruxolitinib Sensitive : D

Associations